Dott. Roberto Pistolesi

Roberto has background in organic chemistry. He frequently advises clients on patent strategies and provides infringement and validity opinions and has an extensive experience both in prosecution and opposition procedures before the EPO, where he has been involved in more than 100 cases before the Opposition Divisions or the Boards of Appeal.

He also has a wide expertise in multi-national patent litigations; in particular, he has been involved as party expert in patent litigations concerning the following active principles: alendronic acid (Fosamax), alirocumab (Praulent), atorvastatine (Torvast), cefaclor, citalopram (Celexa), docetaxel (Taxotere), enoxaparine (Lovenox), esomeprazole (Nexium), everolimus (Linevero), phosphatidylserine, gabapentin (Neurontin), irbesartan+HCTZ (Co-Aprovel), latanoprost (Xalatan), olanzapine (Zyprexa), omega-3, omeprazole (Omeprazen), montelukast (Singulair), natalizumab (Tysabri), quetiapine (Seroquel), ramipril, repaglinide (Novonorm), rupatadine, salmeterol + fluticasone, sildenafil (Viagra), tadalafil (Cialis) and terbinafine (Lamisil).

Roberto has been a technical expert of the Court of Milan since 2002 and of the Court of Venice since 2015, where he assists Judges in patent infringement and/or validity cases; in January 2023 he was appointed as technical expert of the Board of Appeal of the Court of Milan.

He was adjunct Professor at the “Universita’ degli Studi” of Milan from 2011 to 2015, where he taught chemical patent practice to the students of Chemical Science, Industrial Chemistry and Biotechnology.

He has been President of FICPI since September 2022. He was Secretary General of FICPI from April 2015 to September 2022, and chairman of FICPI’s study and work commission dealing with inventions in the pharma and biotech area from April 2012 to April 2015.

He frequently lectures on intellectual property both in Italy and abroad.
He has published several articles on “Il Sole-24 Ore”, “Pharmachem” and “Il Diritto Industriale”; he is co-author of the Italian and European sections of “Biotechnology and Pharmaceutical Patents – Law and Practice”, Wolters Kluwer, 2008 and 2009 editions.

Education

• Degree in Bio-Organic Chemistry (Università degli Studi di Milano)
• CEIPI diploma on patent litigations in Europe

Bar admissions

• Since June 1998: Italian patent agent
• Since September 1999: Italian trademark agent
• Since March 2000: European patent attorney
• Since June 2000: Community trademark attorney
• Since March 2023: Patent litigator admitted before the UPC

Professional Experience

Partner and CEO of Dragotti & Associati.